Paclitaxel targets FOXM1 to regulate KIF20A in mitotic catastrophe and breast cancer paclitaxel resistance

Pasarat Khongkow, Ana Gomes, Chun Gong, +8

Oncogene

SIRT6 modulates paclitaxel and epirubicin resistance and survival in breast cancer

Mattaka Khongkow, Yolanda Olmos, Chun Gong, +13

Carcinogenesis

OTUB1 inhibits the ubiquitination and degradation of FOXM1 in breast cancer and epirubicin resistance

U Karunarathna, Mesayamas Kongsema, Stefania Zona, +10

Oncogene

FOXM1 targets NBS1 to regulate DNA damage-induced senescence and epirubicin resistance

Pasarat Khongkow, U Karunarathna, Mattaka Khongkow, +14

Oncogene

FOXM1 targets XIAP and Survivin to modulate breast cancer survival and chemoresistance

Gabriela Nestal de Moraes, Deborah Delbue, Karina L. Silva, +9

Cellular Signalling

Tumor BiologyBreast OncologyMedicineCancer Cell BiologyFoxm1 Targets Xiap +10

Vesicular carriers containing phenylethyl resorcinol for topical delivery system; liposomes, transfersomes and invasomes

Thanaporn Amnuaikit, Tunyaluk Limsuwan, Pasarat Khongkow, +1

Asian Journal of Pharmaceutical Sciences

SUMOylation inhibits FOXM1 activity and delays mitotic transition

Stephen S. Myatt, Mesayamas Kongsema, Chung Man, +11

Oncogene

The Forkhead Box M1 protein regulates BRIP1 expression and DNA damage repair in epirubicin treatment

Lara J. Monteiro, Pasarat Khongkow, Mesayamas Kongsema, +12

Oncogene

Genome InstabilityBrip1 ExpressionDna Damage RepairMolecular BiologyMolecular Research +3

Ethosomes of Phenylethyl Resorcinol as Vesicular Delivery System for Skin Lightening Applications

Tunyaluk Limsuwan, Prapaporn Boonme, Pasarat Khongkow, +1

BioMed Research International

Overexpression of Forkhead Box Protein M1 (FOXM1) in Ovarian Cancer Correlates with Poor Patient Survival and Contributes to Paclitaxel Resistance

Fung Zhao, Michelle K.Y. Siu, LiLi Jiang, +8

PLoS ONE